Bengaluru: In observance of Rare Disease Day, Strand Life Sciences, a subsidiary of Reliance Industries and a leader in genomics research, has introduced the StrandOmics Portal—an advanced digital platform designed to streamline the diagnosis of rare diseases. The portal aims to assist healthcare professionals in delivering more accurate and timely diagnoses by providing in-depth insights into genetic variants.
This innovative tool is expected to significantly reduce the time and complexity involved in diagnosing rare diseases, offering patients a faster path to proper treatment and care.
In addition to launching the StrandOmics Portal, Strand Life Sciences has rolled out an initiative to make genetic testing more affordable for patients from economically disadvantaged backgrounds, ensuring greater accessibility to these essential diagnostic services.
The StrandOmics Portal equips clinicians with several key advantages, including rapid genetic analysis for quicker diagnoses, the ability to independently review a wider range of genetic variants, and enhanced decision-making support. This platform also fosters improved prenatal diagnosis and facilitates better collaboration among specialists, ultimately leading to improved outcomes for patients with rare genetic conditions.
Dr. Ramesh Hariharan, CEO and Co-Founder of Strand Life Sciences, expressed, “Our commitment to advancing genetic diagnostics and ensuring accessibility for all remains unwavering. With the launch of the StrandOmics Portal, we aim to provide doctors with enhanced tools for diagnosing and treating rare diseases. We will continue to innovate and push the boundaries of genetic testing technology.”
A pioneer in genomic diagnostics in India, Strand Life Sciences is renowned for its work in oncology, rare diseases, women’s health, and infectious diseases. With its expertise in bioinformatics, state-of-the-art laboratory research, and an extensive network of hospital partners, the company is advancing personalized medicine. Furthermore, Strand Life Sciences is expanding into consumer genomics, offering individuals personalized insights into their genetic profiles.
Through the launch of the StrandOmics Portal and its initiative to offer reduced-cost genetic testing for underserved communities, Strand Life Sciences continues its mission to bridge the gap in rare disease diagnosis and treatment accessibility across India.
